Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-national, Randomized, Double-blind, Placebo-controlled, 3-period Crossover Study With GSK 573719 as Monotherapy in Adult Subjects With Asthma

NCT01641692 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01641692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01641692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-national, Randomized, Double-blind, Placebo-controlled, 3-period Crossover Study With GSK 573719 as Monotherapy in Adult Subjects With Asthma
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
February 28, 2013
Enrollment
350 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

asthma